Acute Cardiovascular Care Association position statement for
the diagnosis and treatment of patients with acute myocardial
infarction complicated by cardiogenic shock: A document of the
Acute Cardiovascular Care Association of the European Society
of Cardiology

J 2020

Acute Cardiovascular Care Association position statement for the diagnosis and treatment of patients with acute myocardial infarction complicated by cardiogenic shock: A document of the Acute Cardiovascular Care Association of the European Society of Cardiology

ZEYMER, U., H. BUENO, C. B. GRANGER, J. HOCHMAN, K. HUBER et. al.

Základní údaje

Originální název

Acute Cardiovascular Care Association position statement for the diagnosis and treatment of patients with acute myocardial infarction complicated by cardiogenic shock: A document of the Acute Cardiovascular Care Association of the European Society of Cardiology

Autoři

ZEYMER, U., H. BUENO, C. B. GRANGER, J. HOCHMAN, K. HUBER, M. LETTINO, S. PRICE, F. SCHIELE, M. TUBARO, P. VRANCKX, D. ZAHGER a H. THIELE

Vydání

EUROPEAN HEART JOURNAL-ACUTE CARDIOVASCULAR CARE, LONDON, SAGE PUBLICATIONS LTD, 2020, 2048-8726

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30230 Other clinical medicine subjects

Stát vydavatele

Velká Británie a Severní Irsko

Utajení

není předmětem státního či obchodního tajemství

Odkazy

DAPT-SHOCK AMI

Impakt faktor

Impact factor: 4.696

Kód RIV

RIV/00216224:14110/20:00123182

Organizační jednotka

Lékařská fakulta

DOI

http://dx.doi.org/10.1177/2048872619894254

UT WoS

000517721200001

Klíčová slova česky

DAPT-SHOCK AMI; Acute myocardial infarction; Cardiogenic shock; Revascularuzation therapies; mechanical circulatory support

Klíčová slova anglicky

DAPT-SHOCK AMI; Acute myocardial infarction; Cardiogenic shock; Revascularuzation therapies; mechanical circulatory support

Štítky

Excelence Science, RIV, UK LF PRAHA, user

Příznaky

Mezinárodní význam

Změněno: 10. 2. 2022 13:50, Bc. Hana Vladíková, BBA

Anotace

V originále

(Dual Antiplatelet Therapy for Shock patients with Acute Myocardial Infarction (DAPT-SHOCK-AMI) trial; ClinicalTrials.gov: NCT03551964). Most of the guideline-recommended treatment strategies for patients with acute coronary syndromes have been tested in large randomised clinical trials. Still, a major challenge is represented by patients with acute myocardial infarction admitted with impending or established cardiogenic shock. Despite early revascularization the mortality of cardiogenic shock remains high and roughly half of patients do not survive until hospital discharge or 30-day follow-up. However, there is only limited evidence-based scientific knowledge in the cardiogenic shock setting. Therefore, recommendations and actual treatments are often based on retrospective or prospective registry data and extrapolations from randomised clinical trials in acute myocardial infarction patients without cardiogenic shock. This position statement will summarise the current consensus of the diagnosis and treatment of patients with acute myocardial infarction complicated by cardiogenic shock based on current evidence and will provide advice for clinical practice.

Návaznosti

90128, velká výzkumná infrastruktura

Název: CZECRIN III

Citovat

ZEYMER, U., H. BUENO, C. B. GRANGER, J. HOCHMAN, K. HUBER, M. LETTINO, S. PRICE, F. SCHIELE, M. TUBARO, P. VRANCKX, D. ZAHGER a H. THIELE. Acute Cardiovascular Care Association position statement for the diagnosis and treatment of patients with acute myocardial infarction complicated by cardiogenic shock: A document of the Acute Cardiovascular Care Association of the European Society of Cardiology. EUROPEAN HEART JOURNAL-ACUTE CARDIOVASCULAR CARE. LONDON: SAGE PUBLICATIONS LTD, 2020, roč. 9, č. 2, s. 183-197. ISSN 2048-8726. Dostupné z: https://dx.doi.org/10.1177/2048872619894254.

@article{1808360,
   author = {Zeymer, U. and Bueno, H. and Granger, C. B. and Hochman, J. and Huber, K. and Lettino, M. and Price, S. and Schiele, F. and Tubaro, M. and Vranckx, P. and Zahger, D. and Thiele, H.},
   article_location = {LONDON},
   article_number = {2},
   doi = {http://dx.doi.org/10.1177/2048872619894254},
   keywords = {DAPT-SHOCK AMI; Acute myocardial infarction; Cardiogenic shock; Revascularuzation therapies; mechanical circulatory support},
   language = {eng},
   issn = {2048-8726},
   journal = {EUROPEAN HEART JOURNAL-ACUTE CARDIOVASCULAR CARE},
   note = {DAPT SHOCK AMI (Prague - 23)},
   title = {Acute Cardiovascular Care Association position statement for the diagnosis and treatment of patients with acute myocardial infarction complicated by cardiogenic shock: A document of the Acute Cardiovascular Care Association of the European Society of Cardiology},
   url = {https://academic.oup.com/ehjacc/article/9/2/183/5933392},
   volume = {9},
   year = {2020}
}

TY  - JOUR
ID  - 1808360
AU  - Zeymer, U. - Bueno, H. - Granger, C. B. - Hochman, J. - Huber, K. - Lettino, M. - Price, S. - Schiele, F. - Tubaro, M. - Vranckx, P. - Zahger, D. - Thiele, H.
PY  - 2020
TI  - Acute Cardiovascular Care Association position statement for the diagnosis and treatment of patients with acute myocardial infarction complicated by cardiogenic shock: A document of the Acute Cardiovascular Care Association of the European Society of Cardiology
JF  - EUROPEAN HEART JOURNAL-ACUTE CARDIOVASCULAR CARE
VL  - 9
IS  - 2
SP  - 183-197
EP  - 183-197
PB  - SAGE PUBLICATIONS LTD
SN  - 20488726
N1  - DAPT SHOCK AMI (Prague - 23)
KW  - DAPT-SHOCK AMI
KW  - Acute myocardial infarction
KW  - Cardiogenic shock
KW  - Revascularuzation therapies
KW  - mechanical circulatory support
UR  - https://academic.oup.com/ehjacc/article/9/2/183/5933392
N2  - (Dual Antiplatelet Therapy for Shock patients with Acute Myocardial Infarction (DAPT-SHOCK-AMI) trial; ClinicalTrials.gov: NCT03551964). Most of the guideline-recommended treatment strategies for patients with acute coronary syndromes have been tested in large randomised clinical trials. Still, a major challenge is represented by patients with acute myocardial infarction admitted with impending or established cardiogenic shock. Despite early revascularization the mortality of cardiogenic shock remains high and roughly half of patients do not survive until hospital discharge or 30-day follow-up. However, there is only limited evidence-based scientific knowledge in the cardiogenic shock setting. Therefore, recommendations and actual treatments are often based on retrospective or prospective registry data and extrapolations from randomised clinical trials in acute myocardial infarction patients without cardiogenic shock. This position statement will summarise the current consensus of the diagnosis and treatment of patients with acute myocardial infarction complicated by cardiogenic shock based on current evidence and will provide advice for clinical practice.
ER  -

ZEYMER, U., H. BUENO, C. B. GRANGER, J. HOCHMAN, K. HUBER, M. LETTINO, S. PRICE, F. SCHIELE, M. TUBARO, P. VRANCKX, D. ZAHGER a H. THIELE. Acute Cardiovascular Care Association position statement for the diagnosis and treatment of patients with acute myocardial infarction complicated by cardiogenic shock: A document of the Acute Cardiovascular Care Association of the European Society of Cardiology. \textit{EUROPEAN HEART JOURNAL-ACUTE CARDIOVASCULAR CARE}. LONDON: SAGE PUBLICATIONS LTD, 2020, roč.~9, č.~2, s.~183-197. ISSN~2048-8726. Dostupné z: https://dx.doi.org/10.1177/2048872619894254.

Podrobný výpis o publikaci